Performance analysis of Mira Pharmaceuticals (MIRA)
Annual Return
Since Aug 3, 2023, MIRA has had an average annual return of -50.02%, underperforming the benchmark SPY, which returned +21.89% annual.
| 2026 | 2025 | 2024 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.11% | +32.49% | +8.55% | -85.85% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.89% | +2.45% | -15.77% | -1.87% | +0.99% | -1.89% | -31.11% | ||||||
| 2025 | +5.27% | -16.64% | -2.00% | +18.32% | +16.38% | -10.34% | +36.36% | -17.00% | -0.70% | +22.80% | -11.37% | +2.01% | +32.49% |
| 2024 | -10.46% | +6.87% | +9.45% | -22.74% | -3.67% | -22.21% | +229.84% | -8.09% | -32.64% | +68.44% | -41.07% | -11.67% | +8.55% |
| 2023 | -15.45% | -25.88% | -58.27% | +82.94% | -70.42% | -85.85% |
Drawdown analysis of Mira Pharmaceuticals (MIRA)
The maximum drawdown for the MIRA was -92.69%, occurring on Jul 9, 2024. This drawdown has not yet recovered.
The current MIRA drawdown is -85.98%.
Since Aug 3, 2023 MIRA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.69% | Aug 3, 2023 | 233 | Jul 9, 2024 | Ongoing | Ongoing | Ongoing |